| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hyphens Pharma International Limited (SG: 1J5)
1J5 Technical Analysis
3
| As on 21st Nov 2024 1J5 STOCK Price closed @ 0.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.28 & Buy for SHORT-TERM with Stoploss of 0.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1J5STOCK Price
| Open | 0.29 | Change | Price | % |
| High | 0.30 | 1 Day | 0.00 | 0.00 |
| Low | 0.29 | 1 Week | 0.02 | 7.14 |
| Close | 0.30 | 1 Month | 0.01 | 3.45 |
| Volume | 33800 | 1 Year | 0.02 | 7.14 |
| 52 Week High 0.32 | 52 Week Low 0.26 | ||||
SG Singapore Most Active Stocks
| S51 | 1.39 | -5.44% |
| 579 | 0.01 | % |
| G13 | 0.76 | -2.56% |
| C38U | 1.93 | -0.52% |
| Z74 | 3.06 | -2.24% |
| Y92 | 0.52 | 0.00% |
| BS6 | 2.67 | 0.75% |
| M44U | 1.26 | 0.80% |
| K71U | 0.85 | -1.16% |
| FQ7 | 0.00 | % |
SG Singapore Top Gainers Stocks
SG Singapore Top Losers Stocks
| 1J5 Daily Charts |
1J5 Intraday Charts |
Whats New @ Bazaartrend |
1J5 Free Analysis |
|
|
1J5 Important Levels Intraday
| RESISTANCE | 0.32 |
| RESISTANCE | 0.31 |
| RESISTANCE | 0.31 |
| RESISTANCE | 0.31 |
| SUPPORT | 0.29 |
| SUPPORT | 0.29 |
| SUPPORT | 0.29 |
| SUPPORT | 0.28 |
1J5 Forecast November 2024
| 4th UP Forecast | 0.38 |
| 3rd UP Forecast | 0.35 |
| 2nd UP Forecast | 0.34 |
| 1st UP Forecast | 0.32 |
| 1st DOWN Forecast | 0.28 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | 0.25 |
| 4th DOWN Forecast | 0.22 |
1J5 Weekly Forecast
| 4th UP Forecast | 0.32 |
| 3rd UP Forecast | 0.31 |
| 2nd UP Forecast | 0.31 |
| 1st UP Forecast | 0.31 |
| 1st DOWN Forecast | 0.29 |
| 2nd DOWN Forecast | 0.29 |
| 3rd DOWN Forecast | 0.29 |
| 4th DOWN Forecast | 0.28 |
1J5 Forecast2024
| 4th UP Forecast | 0.42 |
| 3rd UP Forecast | 0.38 |
| 2nd UP Forecast | 0.36 |
| 1st UP Forecast | 0.33 |
| 1st DOWN Forecast | 0.27 |
| 2nd DOWN Forecast | 0.24 |
| 3rd DOWN Forecast | 0.22 |
| 4th DOWN Forecast | 0.18 |
Hyphens Pharma International Limited ( SG Singapore Symbol : 1J5 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1J5 Business Profile
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, the Philippines, Indonesia, and Malaysia. The company's Specialty Pharma Principals segment sells and markets specialty pharmaceutical products, including Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup, Lidose, and Piascledine through distributorship or licensing, and supply agreements. This segment offers products in various therapeutic areas or medical specialties, including dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedic and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, child psychiatry, and family medicine. Its Proprietary Brands segment develops, markets, and sells dermatological products and health supplement products. It offers dermocosmetic products under the Ceradan and TDF brands through medical professionals, such as general practitioners, dermatologists, pediatricians, and pharmacists; health supplement products under the Ocean Health brand directly to consumers via retail channels; and scalp care products under the CG 210 brand. The company's Medical Hypermart and Digital segment engages in the wholesale of pharmaceuticals and medical supplies for healthcare professionals and institutions, and retail pharmacies through tele-sales and sales representatives. This segment also operates an online B2B platform. It also markets and distributes its products in Bangladesh, Brunei, Cambodia, China, Hong Kong, Macau, Myanmar, Oman, Sri Lanka, and South Korea. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. It was founded in 1998 and is headquartered in Singapore. Hyphens Pharma International Limited is a subsidiary of Inomed Holding Pte Ltd. Address: 16 Tai Seng Street, Singapore, Singapore, 534138
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service